Login / Signup

Inhibiting anti-angiogenic VEGF165b activates a miR-17-20a-Calcipressin-3 pathway that revascularizes ischemic muscle in peripheral artery disease.

Sonia BatanSivaraman KuppuswamyMadison WoodMeghana ReddyBrian H AnnexVijay C Ganta
Published in: Communications medicine (2024)
b-inhibition in PAD.
Keyphrases
  • peripheral artery disease
  • cell proliferation
  • long non coding rna
  • vascular endothelial growth factor
  • long noncoding rna
  • skeletal muscle
  • signaling pathway
  • endothelial cells
  • ischemia reperfusion injury